This Is What Whales Are Betting On Gilead Sciences
Portfolio Pulse from Benzinga Insights
A significant investor has taken a bearish stance on Gilead Sciences (NASDAQ:GILD), with 53% of recent trades being bearish. The whales have been targeting a price range from $75.0 to $77.5 for Gilead Sciences over the last 3 months. RBC Capital has downgraded its action to Sector Perform with a price target of $88.
June 30, 2023 | 3:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bearish stance taken by a significant investor on Gilead Sciences. RBC Capital downgrades to Sector Perform.
The bearish stance taken by a significant investor and the downgrade by RBC Capital could negatively impact Gilead Sciences' stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100